High-resolution MR lymphography using ultrasmall superparamagnetic iron oxide (USPIO) in the evaluation of axillary lymph nodes in patients with early stage breast cancer: preliminary results

Kimura, Kosei; Tanigawa, Nobuhiko; Matsuki, Mitsuru; Nohara, Takehiro; Iwamoto, Mitsuhiko; Sumiyoshi, Kazuhiro; Tanaka, Satoru; Takahashi, Yuko; Narumi, Yasuo

doi:10.1007/s12282-009-0143-7

Cited by 36 publications

(30 citation statements)

References 26 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The characteristics of the nine 41,42,64,[108][109][110][111][112][113] included studies of MRI for assessment of the axilla are described in Table 8. There were five studies of USPIO-enhanced MRI, [108][109][110][111][112] two studies of dynamic gadolinium-enhanced MRI, 41,113 one study of (non-dynamic) gadolinium-enhanced MRI, 42 and one study of in vivo proton MR spectroscopy.…”

Section: Magnetic Resonance Imaging Studiesmentioning

confidence: 99%

“…There were five studies of USPIO-enhanced MRI, [108][109][110][111][112] two studies of dynamic gadolinium-enhanced MRI, 41,113 one study of (non-dynamic) gadolinium-enhanced MRI, 42 and one study of in vivo proton MR spectroscopy. 64 Several of the studies reported more than one set of results on diagnostic accuracy, according to different criteria for defining whether axillary metastases were present (e.g.…”

Section: Magnetic Resonance Imaging Studiesmentioning

confidence: 99%

“…108 Five studies recruited patients both prospectively and consecutively. 64,[108][109][110]112 The number of analysed patients (relevant to this review) ranged from 10 to 75.…”

Section: Magnetic Resonance Imaging Studiesmentioning

confidence: 99%

See 2 more Smart Citations

Positron emission tomography (PET) and magnetic resonance imaging (MRI) for the assessment of axillary lymph node metastases in early breast cancer: systematic review and economic evaluation

Cooper

Meng²,

Harnan³

et al. 2011

Health Technol Assess

View full text Add to dashboard Cite

An electronic version of this title, in Adobe Acrobat format, is available for downloading free of charge for personal use from the HTA website (www.hta.ac.uk). A fully searchable DVD is also available (see below).Printed copies of HTA journal series issues cost £20 each (post and packing free in the UK) to both public and private sector purchasers from our despatch agents.Non-UK purchasers will have to pay a small fee for post and packing. For European countries the cost is £2 per issue and for the rest of the world £3 per issue. How to order:-fax (with credit card details) -post (with credit card details or cheque) -phone during office hours (credit card only).Additionally the HTA website allows you to either print out your order or download a blank order form. Contact details are as follows:Synergie UK (HTA Department) Digital House, The Loddon Centre Wade Road Basingstoke Hants RG24 8QW Email: orders@hta.ac.uk Tel: 0845 812 4000 -ask for 'HTA Payment Services' (out-of-hours answer-phone service) Fax: 0845 812 4001 -put 'HTA Order' on the fax header Payment methods Paying by chequeIf you pay by cheque, the cheque must be in pounds sterling, made payable to University of Southampton and drawn on a bank with a UK address.Paying by credit card You can order using your credit card by phone, fax or post. SubscriptionsNHS libraries can subscribe free of charge. Public libraries can subscribe at a reduced cost of £100 for each volume (normally comprising 40-50 titles). The commercial subscription rate is £400 per volume (addresses within the UK) and £600 per volume (addresses outside the UK). Please see our website for details. Subscriptions can be purchased only for the current or forthcoming volume.How do I get a copy of HTA on DVD?Please use the form on the HTA website (www.hta.ac.uk/htacd/index.shtml). HTA on DVD is currently free of charge worldwide.The website also provides information about the HTA programme and lists the membership of the various committees. HTA NIHR Health Technology Assessment programmeThe Health Technology Assessment (HTA) programme, part of the National Institute for Health Research (NIHR), was set up in 1993. It produces high-quality research information on the effectiveness, costs and broader impact of health technologies for those who use, manage and provide care in the NHS. 'Health technologies' are broadly defined as all interventions used to promote health, prevent and treat disease, and improve rehabilitation and long-term care. The research findings from the HTA programme directly influence decision-making bodies such as the National Institute for Health and Clinical Excellence (NICE) and the National Screening Committee (NSC). HTA findings also help to improve the quality of clinical practice in the NHS indirectly in that they form a key component of the 'National Knowledge Service' . The HTA programme is needs led in that it fills gaps in the evidence needed by the NHS. There are three routes to the start of projects. First is the commissioned route. Suggestions for research a...

show abstract

Section: Magnetic Resonance Imaging Studiesmentioning

confidence: 99%

Section: Magnetic Resonance Imaging Studiesmentioning

confidence: 99%

See 1 more Smart Citation

Positron emission tomography (PET) and magnetic resonance imaging (MRI) for the assessment of axillary lymph node metastases in early breast cancer: systematic review and economic evaluation

Cooper

Meng²,

Harnan³

et al. 2011

Health Technol Assess

View full text Add to dashboard Cite

show abstract

“…The highest mean sensitivity and specificity was recorded for ultra-small paramagnetic iron oxide (USPIO) enhanced MRI, with values of 98 (95 % CI 61-100 %) and 96 % (95 % CI 72-100 %), respectively. Kimura et al [32] found that MRI lymphangiograhy with USPIO, performed on 10 patients with breast cancer, was able to accurately predict all metastatic and normal nodes pre-operatively. However, only Motomura et al [26] performed a breakdown of their identification of metastatic axillary lymph nodes according to micro or macrometastases.…”

Section: The Future Role Of Mnps In the Management Of The Axilla In Bmentioning

confidence: 99%

What is the future of magnetic nanoparticles in the axillary management of breast cancer?

Ahmed

Douek

2013

Breast Cancer Res Treat

View full text Add to dashboard Cite

Magnetic nanoparticles (MNPs) possess unique properties, which make them highly attractive for medical applications. The use of MNPs in surgery has mainly been focused on their role in the identification of metastatic lymph node involvement. There have been developments within this field, including ongoing and newly conducted clinical trials. The current published evidence for the use of MNPs in assessing metastatic lymph node spread using sentinel lymph node biopsy and non-invasive imaging modalities is reviewed and future applications considered.

show abstract

“…The ct used in radiotherapy planning has known limitations with respect to lymph node identification and delineation. When added to preoperative diagnostic ct, complementary imaging modalities such as mri and mri with novel lymphotrophic contrast agents such as ultrasmall particles of iron oxide may help to ensure more accurate staging and nodal volume delineation 12 . However, both of the latter modalities are limited, because the positioning of the patient during the scans is different from that used for radiotherapy treatment.…”

Section: A B Figure 2 Level I Axillary Nodes (Green) With New Recurrementioning

confidence: 99%

Caught in the Middle: Case Study of a Brachial (Sentry) Lymph Node Recurrence after Resection and Locoregional Breast Radiotherapy

et al. 2012

View full text Add to dashboard Cite

show abstract

High-resolution MR lymphography using ultrasmall superparamagnetic iron oxide (USPIO) in the evaluation of axillary lymph nodes in patients with early stage breast cancer: preliminary results

Abstract: High-resolution MR lymphography using USPIO enabled us to obtain good axillary lymph node evaluation results. These results suggest that this method of imaging may contribute to better preoperative lymph node staging.

Cited by 36 publications

References 26 publications

Positron emission tomography (PET) and magnetic resonance imaging (MRI) for the assessment of axillary lymph node metastases in early breast cancer: systematic review and economic evaluation

Positron emission tomography (PET) and magnetic resonance imaging (MRI) for the assessment of axillary lymph node metastases in early breast cancer: systematic review and economic evaluation

What is the future of magnetic nanoparticles in the axillary management of breast cancer?

Caught in the Middle: Case Study of a Brachial (Sentry) Lymph Node Recurrence after Resection and Locoregional Breast Radiotherapy

Contact Info

Product

Resources

About